- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
GTx Inc+ Add to Watchlist
GTXI:US0.7230 USD 0.0170 2.30%
As of 20:10:00 ET on 04/17/2015.
Company Profile for GTx Inc (GTXI)
GTx, Inc. discovers, develops, and commercializes therapeutics primarily related to the treatment of serious men's health conditions. The Company's drug discover and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones. GTx is currently developing products for prostate cancer.
Key Executives for GTx Inc (GTXI)
|Robert J Wills "Rob"Chairman||Marc S HanoverPresident/CEO/COO/Co-Founder|
|Henry P DoggrellVP/Chief Legal Officer/Secy||Jeffrey G HesselbergVP:Regulatory Affairs|
|Mary Ann JohnstonVP:Medical Affairs||Jason T ShackelfordSenior Dir:Acctg/Controller|